Industry bemoans lack of incentives despite biotech budget hike
By T.V. Padma
Wednesday, February 8, 2017
NEW DELHI – A significant boost to India's Department of Biotechnology (DBT) in the country's latest budget has nevertheless left the domestic industry unimpressed and unenthused, with critics noting there are few new incentives to help the sector.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.